Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases.
Mori R, Abe M, Saimoto Y, Shinto S, Jodai S, Tomomatsu M, Tazoe K, Ishida M, Enoki M, Kato N, Yamashita T, Itabashi Y, Nakanishi I, Ohkubo K, Kaidzu S, Tanito M, Matsuoka Y, Morimoto K, Yamada KI.
Mori R, et al. Among authors: yamada ki.
Redox Biol. 2024 May 8;73:103186. doi: 10.1016/j.redox.2024.103186. Online ahead of print.
Redox Biol. 2024.
PMID: 38744193